- Global Pharma News & Resources

Global Proteomics market to touch US$ 53.4 Bn by 2025 at a CAGR of 15.2%

Noida, Uttar Pradesh, India, March 25 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Along with the increasing focus on targeted drug delivery systems, researchers globally show a keen interest in integrating AI in proteomics research. AI & Medicine, the New York-based company, announced to release targeted proteomics and biomarker discovery services for researchers across the globe. This move is made to meet the rising demand for new biomarkers in most pathology areas, particularly in cancer diagnostics.


China is also undergoing the development of AI programs and computational power to discover new drugs and treatments. The growing investment in scientific research and the development in medical diagnostic and treatment will drive the growth of the proteomics market during the forecast period. iCarbonX, a Chinese company that collects data of the genetics of millions of patients, utilizes AI and data mining for treatments based on a digital view. Prosit, an AI software, is a breakthrough in proteomics research. Prosit is trained on around 100 million mass spectra and can be used for all standard mass spectrometers without additional training. Following these promising developments, the Global Proteomics Market is estimated to see healthy growth, pegged at a CAGR of around 15.2% throughout the forecast period 2020-2025.

Along with enhancing mass spectrometry for proteomics, AI helps speed up massive datasets analysis. Conventional methods, such as fluorescence resonance energy transfer (FRET) and microscopy techniques, call for a high level of expertise. Researchers from the Niels Bohr Institute and the Novo Nordisk Foundation Center for Protein Research have developed a machine-learning algorithm to quickly recognize protein patterns, letting data classification classify in mere seconds.

Researchers have made a breakthrough using AI that could revolutionize the hunt for novel medicines. Scientists have created AI software that employs a protein’s DNA sequence to predict its 3D structure within an atom’s accuracy width. Across over 100 proteins, DeepMind’s AI software, which is called AlphaFold 2, was able to expect the structure to within about an atom’s width of accuracy in two-thirds of cases and was highly accurate in most of the remaining one-third of patients. Therefore, considerable growth can be projected in the proteomics market post the wide implementation of AI in the proteomics field in the near future.

Segmentation Overview of the Global Proteomics Market

The proteomics market is segmented based on instrumentation technology, reagents, application, and end user. These major market segments are further categorized into various sub-segments to study the market in detail.

By Instrumentation Technology Outlook (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, Others)

By Reagents Outlook (Immunoassay Reagent, Protein Microarray Reagents, Chromatography Reagents, Spectroscopy Reagents, Others)

By Application Outlook (Clinical Diagnostics, Drug Discovery, Others)

By End User Outlook (Hospitals & Clinics, Pharmaceutical Companies, Academic Research Laboratories)

Key Players Insights

Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Luminex Corporation, PerkinElmer Inc., Waters Corporation, Illumina, Inc., Eurofins Scientific, QIAGEN Bioinformatics, Creative Proteomics, Promega Corporation, among others, are some significant players included in the research study of the global proteomics market.

Download Exclusive Sample Report (250 Pages PDF with All Related Graphs & Charts) @

This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 25-Mar-2021